112 related articles for article (PubMed ID: 35256559)
1. Pharmacological activation of kappa opioid receptors in the nucleus accumbens core and ventral tegmental area increases the aversive effects of nicotine.
Pham H; Seeley SL; D'Souza MS
Behav Pharmacol; 2022 Jun; 33(4):266-281. PubMed ID: 35256559
[TBL] [Abstract][Full Text] [Related]
2. Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
Ward M; Norman H; D'Souza MS
Behav Brain Res; 2018 Feb; 338():56-65. PubMed ID: 29037662
[TBL] [Abstract][Full Text] [Related]
3. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.
Tejeda HA; Natividad LA; Orfila JE; Torres OV; O'Dell LE
Psychopharmacology (Berl); 2012 Nov; 224(2):289-301. PubMed ID: 22659976
[TBL] [Abstract][Full Text] [Related]
5. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
Tabbara RI; Fletcher PJ
Neuropharmacology; 2019 Apr; 148():68-76. PubMed ID: 30550794
[TBL] [Abstract][Full Text] [Related]
6. Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.
Ehrich JM; Phillips PE; Chavkin C
Neuropsychopharmacology; 2014 Dec; 39(13):3036-48. PubMed ID: 24971603
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
D'Souza MS; Markou A
Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
[TBL] [Abstract][Full Text] [Related]
8. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
[TBL] [Abstract][Full Text] [Related]
9. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.
Chefer VI; Bäckman CM; Gigante ED; Shippenberg TS
Neuropsychopharmacology; 2013 Dec; 38(13):2623-31. PubMed ID: 23921954
[TBL] [Abstract][Full Text] [Related]
10. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.
Fu Y; Matta SG; Gao W; Brower VG; Sharp BM
J Pharmacol Exp Ther; 2000 Aug; 294(2):458-65. PubMed ID: 10900219
[TBL] [Abstract][Full Text] [Related]
11. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
[TBL] [Abstract][Full Text] [Related]
12. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
Laman-Maharg AR; Copeland T; Sanchez EO; Campi KL; Trainor BC
Behav Brain Res; 2017 Aug; 332():299-307. PubMed ID: 28625549
[TBL] [Abstract][Full Text] [Related]
13. Differential role of N-methyl-D-aspartate receptor-mediated glutamate transmission in the nucleus accumbens shell and core in nicotine seeking in rats.
D'Souza MS; Markou A
Eur J Neurosci; 2014 Apr; 39(8):1314-22. PubMed ID: 24467279
[TBL] [Abstract][Full Text] [Related]
14. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.
Conway SM; Puttick D; Russell S; Potter D; Roitman MF; Chartoff EH
Neuropharmacology; 2019 Mar; 146():231-241. PubMed ID: 30528327
[TBL] [Abstract][Full Text] [Related]
15. Learned avoidance requires VTA KOR-mediated reductions in dopamine.
Robble MA; Bozsik ME; Wheeler DS; Wheeler RA
Neuropharmacology; 2020 May; 167():107996. PubMed ID: 32057802
[TBL] [Abstract][Full Text] [Related]
16. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum.
Mitrovic I; Napier TC
Eur J Neurosci; 2002 Jan; 15(2):257-68. PubMed ID: 11849293
[TBL] [Abstract][Full Text] [Related]
17. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.
Schilström B; Nomikos GG; Nisell M; Hertel P; Svensson TH
Neuroscience; 1998 Feb; 82(3):781-9. PubMed ID: 9483535
[TBL] [Abstract][Full Text] [Related]
19. Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
Rahman S; Zhang Z; Papke RL; Crooks PA; Dwoskin LP; Bardo MT
Br J Pharmacol; 2008 Feb; 153(4):792-804. PubMed ID: 18059317
[TBL] [Abstract][Full Text] [Related]
20. Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area.
Laviolette SR; Alexson TO; van der Kooy D
J Neurosci; 2002 Oct; 22(19):8653-60. PubMed ID: 12351739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
